0001179110-18-010987.txt : 20180829 0001179110-18-010987.hdr.sgml : 20180829 20180829145110 ACCESSION NUMBER: 0001179110-18-010987 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180828 FILED AS OF DATE: 20180829 DATE AS OF CHANGE: 20180829 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Taylor Beth CENTRAL INDEX KEY: 0001522046 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35050 FILM NUMBER: 181044067 MAIL ADDRESS: STREET 1: 3000 KENT AVENUE STREET 2: SUITE A1-100 CITY: WEST LAFAYETTE STATE: IN ZIP: 47906 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENDOCYTE INC CENTRAL INDEX KEY: 0001235007 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3000 KENT AVE STE A1-100 CITY: WEST LAFAYETTE STATE: IN ZIP: 47906 BUSINESS PHONE: 7654637175 MAIL ADDRESS: STREET 1: 3000 KENT AVE STE A1-100 CITY: WEST LAFAYETTE STATE: IN ZIP: 47906 4 1 edgar.xml FORM 4 - X0306 4 2018-08-28 0 0001235007 ENDOCYTE INC ECYT 0001522046 Taylor Beth 3000 KENT AVE, STE A1-100 WEST LAFAYETTE IN 47906 0 1 0 0 VP Finance & Chief Acctg Offcr Common Stock 2018-08-28 4 S 0 7892 20.0000 D 63363 D Represents the sale of 7,892 shares in a single transaction, at a price per share of $20.0000. The shares were sold by Merrill Lynch pursuant to a written plan as specified in Rule 10b5-1(c) of the Securities Exchange Act of 1934. /s/ Beth A. Taylor 2018-08-29